Medication paths
Prescription semaglutide and tirzepatide plans, including compounded combinations, via physician consult (provider-reported; clinician evaluation required)
Provider profile · source-bound facts
RetaClinic
Readers comparing provider-reported prescription GLP-1 plan information
Enrollment link pending verificationNo destination appears until Clinic Scout verifies it.
Read editorial evidence
Medication and plan pricing
Treatments
No current source-dated price row is bound.
Clinic Scout does not estimate the missing amount.
At a glance
Unknown is kept separate from a verified negative.
Insurance
UNKNOWN; terms describe cash-pay purchases. Confirm directly before relying on coverage.
Consultation or membership
Reported information: initial and refill consultations are free; clinician intake review is included in the protocol price.
View consultation or membership source · current as of 2026-10-10Shipping or timing
Reported typical turnaround is a few business days after clinician approval. An exact delivery date remains UNKNOWN; this is a provider estimate, not a guarantee.
View shipping or timing source · current as of 2026-10-10Cancellation
Reported cancellation through the patient portal; the FAQ offers a full refund before shipment. The terms say shipped custom compounded products cannot be returned. Renewal cancellation cutoff remains UNKNOWN.
View cancellation source · current as of 2026-10-10State evidence
The homepage reports availability in all 50 states. Treatment-specific restrictions and independent coverage verification remain UNKNOWN.
View state evidence source · current as of 2026-10-10Editorial tradeoffs
Useful for comparing: Readers comparing provider-reported prescription GLP-1 plan information
Limitations in the record
- Exact upfront and renewal bills remain unknown
- Dispensing pharmacy identity and 503A/503B classification remain unknown
Feature evidence and unknowns
Reported typical turnaround is a few business days after clinician approval. An exact delivery date remains UNKNOWN; this is a provider estimate, not a guarantee.
RetaClinic states: Compounded medications are not FDA-approved as finished drug products. They are prepared for individual patients at US-licensed compounding pharmacies. Your physician will discuss benefits and risks during your consult. Dispensing pharmacy identity and 503A/503B classification remain UNKNOWN; no independent licensing verification is asserted. FDA risk note: RetaClinic’s pages also list retatrutide, which its product page labels Research Use Only. FDA states that retatrutide cannot be used in compounding under federal law, is not a component of any FDA-approved drug and has not been found safe and effective for any condition, and that it has warned telehealth companies for marketing unapproved drugs such as retatrutide. This review does not cover or recommend retatrutide.
Clinic Scout patient reviews
Share your experienceNo Clinic Scout patient reviews are published for this provider. Submissions are checked before publication.
Methodology and evidence boundary
Provider names and links come from our reviewed provider list. Prices come from our dated price records; each price links to the source it was taken from, with the date we checked it. Program facts come from our reviewed notes on those dated sources. Clinic Scout does not infer availability, medical fit, ratings, or review counts.
Affiliate and ranking methodology